13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001214659-23-007097
Total Value
$513.0M
Positions
22
Other Managers
0
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IVERIC BIO INC | 46583P102 | 5,141,118 | $125.1M | 24.38% |
| 2 | COGENT BIOSCIENCES INC | COGT | 3,631,042 | $39.2M | 7.64% |
| 3 | GERON CORP | GERN | 17,765,213 | $38.6M | 7.51% |
| 4 | MADRIGAL PHARMACEUTICALS INC | MDGL | 149,917 | $36.3M | 7.08% |
| 5 | TYRA BIOSCIENCES INC | TYRA | 1,989,103 | $32.0M | 6.23% |
| 6 | VENTYX BIOSCIENCES, INC | 92332V107 | 815,724 | $27.3M | 5.33% |
| 7 | KALVISTA PHARMACEUTICALS, INC | KALV | 3,395,495 | $26.7M | 5.20% |
| 8 | CYMABAY THERAPEUTICS INC | 23257D103 | 3,048,257 | $26.6M | 5.18% |
| 9 | VECTIVBIO HOLDING AG | H9060V101 | 3,113,600 | $26.5M | 5.16% |
| 10 | AEROVATE THERAPEUTICS INC | 008064107 | 1,081,274 | $21.8M | 4.25% |
| 11 | DYNE THERAPEUTICS, INC | DYN | 1,650,150 | $19.0M | 3.71% |
| 12 | KURA ONCOLOGY INC | KURA | 1,423,642 | $17.4M | 3.39% |
| 13 | VIRIDIAN THERAPEUTICS, INC | VRDN | 663,610 | $16.9M | 3.29% |
| 14 | SILENCE THERAPEUTICS PLC | SLNCF | 2,104,875 | $13.1M | 2.54% |
| 15 | IMMUNOVANT, INC | IMVT | 654,853 | $10.2M | 1.98% |
| 16 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $8.5M | 1.65% |
| 17 | STRUCTURE THERAPEUTICS INC | GPCR | 350,000 | $8.3M | 1.62% |
| 18 | MERUS BV | N5749R100 | 300,000 | $5.5M | 1.08% |
| 19 | ACLARIS THERAPEUTICS INC | ACRS | 529,839 | $4.3M | 0.84% |
| 20 | CABALETTA BIO, INC | CABA | 486,795 | $4.0M | 0.78% |
| 21 | C4 THERAPEUTICS, INC. | CCCC | 1,250,000 | $3.9M | 0.77% |
| 22 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 253,069 | $2.0M | 0.38% |